Seminars in Hematology
Volume 41, Issue 1 , Pages 15-23, January 2004

Cleavage of von Willebrand factor by ADAMTS-13 on endothelial cells

  • José A López

      Affiliations

    • Corresponding Author InformationAddress correspondence to José A. López, MD, Thrombosis Research Section, Department of Medicine, BCM286, N1319, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
    • Division of Thrombosis Research, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
  • ,
  • Jing-fei Dong

      Affiliations

    • Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA

Abstract 

When histamine-stimulated endothelial cells are perfused with platelets in buffer, the platelets form long beads-on-a-string structures on the surface of the cells. The strands connecting the platelets are composed of ultralarge multimers of von Willebrand factor (ULVWF) and can be rapidly cleaved when perfused with normal plasma or purified ADAMTS-13 metalloprotease, but not with plasma from patients with either congenital or acquired thrombotic thrombocytopenic purpura (TTP). These ULVWF strings anchor to the surface of the endothelial cell at least partly through P-selectin, as their formation is prevented by either soluble P-selectin or P-selectin antibodies. They are also able to support the attachment of beads coated with ADAMTS-13. The metalloprotease binds to both the A1 and A3 domains of VWF, the latter with higher affinity. This attachment docks the enzyme close to its substrate site within the A2 domain. We propose that attachment of newly released ULVWF to the endothelial cell surface facilitates its cleavage by ADAMTS-13 by allowing tensile force to be applied to the A2 domain, thereby exposing the ADAMTS-13 cleavage site.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by a Specialized Centers in Hemostatic and Thrombotic Diseases grant from the National Institutes of Health, no. P50 HL65967.

PII: S0037-1963(03)00269-5

doi:10.1053/j.seminhematol.2003.10.004

Seminars in Hematology
Volume 41, Issue 1 , Pages 15-23, January 2004